Q. Jiang

Y. Pommier, M. Raffeld, R. Chari, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models

S. Steinberg, I. Pastan, A. Ghafoor, 2020, Science Translational Medicine.

Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity

M. Diaz, A. Vaughan, G. Loredo, 2005, Leukemia.

Surviving apoptosis: a possible mechanism of benzene-induced leukemia.

M. Diaz, A. Vaughan, Q. Jiang, 2005, Chemico-biological interactions.

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma

E. Ruppin, Jun S. Wei, J. Lee, 2023, Cell reports. Medicine.

Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma

E. Ruppin, Jun S. Wei, J. Lee, 2022, bioRxiv.

Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.

R. Fisher, T. Grogan, D. Catovsky, 2005, Cancer research.

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

J. Weiss, J. Stauffer, Q. Jiang, 2015, Journal of hepatology.

Macrophage inducible nitric oxide synthase circulates inflammation and promotes lung carcinogenesis

Q. Jiang, Na-Young Song, Yinling Hu, 2018, Cell Death Discovery.

miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47.

Q. Jiang, Wei-Bing Liu, 2018, Medecine sciences : M/S.

NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells

N. Wu, Chuanjian Lu, Q. Jiang, 2018, OncoTargets and therapy.

Abstract 1083: The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas.

R. Goldszmid, S. Xi, D. Schrump, 2013 .

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors

Mitchell Ho, I. Pastan, Q. Jiang, 2022, Molecular cancer therapeutics.

Macrophage inducible nitric oxide synthase circulates inflammation and promotes lung carcinogenesis

Q. Jiang, Na-Young Song, Yinling Hu, 2018, Cell Death Discovery.

NAV‐003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors

Q. Jiang, N. Nicolaides, L. Grasso, 2023, European journal of immunology.

mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.

J. Weiss, S. Guichard, Q. Jiang, 2011, Cancer research.

The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

G. Trinchieri, R. Goldszmid, S. Xi, 2013, Cancer cell.

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

Q. Jiang, T. Back, R. Wiltrout, 2015, Journal of hepatology.

Establishment of an induced pluripotent stem cell line (SHFDi001-A) from a patient with ankylosing spondylitis.

N. Wu, Chuanjian Lu, Q. Jiang, 2020, Stem cell research.